Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Leung

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Postgraduate Medical Journal|April 17, 2023
Safety and tolerability of subcutaneous trastuzumab and intravenous pertuzumab as adjuvant treatment for HER2 positive breast cancer: a pilot studyChi Yan Wong, Roland Leung, Gin Wai Kwok, et al.
Annals of Surgical Oncology|May 12, 2012
Is there a role for unstimulated thyroglobulin velocity in predicting recurrence in papillary thyroid carcinoma patients with detectable thyroglobulin after radioiodine ablation?Hilda Wong, Kai P Wong, Thomas Yau, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|January 1, 2014
Efficacy and tolerability of adjuvant oral capecitabine plus intravenous oxaliplatin (XELOX) in Asian patients with colorectal cancer: 4-year analysisJoanne Chiu, Vikki Tang, Roland Leung, et al.
Postgraduate Medical Journal|November 13, 2016
The real-world use of regorafenib for metastatic colorectal cancer: multicentre analysis of treatment pattern and outcomes in Hong KongKa-On Lam, Kin-Chung Lee, Joanne Chiu, et al.
Thrombosis and Haemostasis|March 31, 2010
Calpain inhibition by calpeptin does not prevent APLT activity reduction in PS-exposing platelets, but calpeptin has independent pro-apoptotic effectsAdam M Gwozdz, Roland Leung, Hong Wang, et al.
The Oncologist|August 14, 2014
Advanced pancreatic cancer: flourishing novel approaches in the era of biological therapyJoanne W Chiu, Hilda Wong, Roland Leung, et al.
Anti-Cancer Agents in Medicinal Chemistry|October 25, 2012
Advances in the systemic treatment of neuroendocrine tumors in the era of molecular therapyRoland Leung, Brian Lang, Hilda Wong, et al.
Cancers|May 4, 2026
Anti-Tumor Immunity in Solid-Organ Transplant RecipientsJeffrey Sum Lung Wong, Karen Hoi Lam Li, Bryan Li, et al.
Advances in Therapy|October 26, 2021
Neoadjuvant Therapy with Concurrent Docetaxel, Epirubicin, and Cyclophosphamide (TEC) in High-Risk HER2-Negative Breast CancersBryan Li, Thomas Yau, Roland Leung, et al.
Expert Review of Gastroenterology & Hepatology|March 5, 2021
Nivolumab + Ipilimumab for patients with hepatocellular carcinoma previously treated with SorafenibJosephine Tsang, Jeffrey Sum Lung Wong, Gerry Gin Wai Kwok, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Postgraduate Medical Journal|April 17, 2023
Safety and tolerability of subcutaneous trastuzumab and intravenous pertuzumab as adjuvant treatment for HER2 positive breast cancer: a pilot studyChi Yan Wong, Roland Leung, Gin Wai Kwok, et al.
Annals of Surgical Oncology|May 12, 2012
Is there a role for unstimulated thyroglobulin velocity in predicting recurrence in papillary thyroid carcinoma patients with detectable thyroglobulin after radioiodine ablation?Hilda Wong, Kai P Wong, Thomas Yau, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|January 1, 2014
Efficacy and tolerability of adjuvant oral capecitabine plus intravenous oxaliplatin (XELOX) in Asian patients with colorectal cancer: 4-year analysisJoanne Chiu, Vikki Tang, Roland Leung, et al.
Postgraduate Medical Journal|November 13, 2016
The real-world use of regorafenib for metastatic colorectal cancer: multicentre analysis of treatment pattern and outcomes in Hong KongKa-On Lam, Kin-Chung Lee, Joanne Chiu, et al.
Thrombosis and Haemostasis|March 31, 2010
Calpain inhibition by calpeptin does not prevent APLT activity reduction in PS-exposing platelets, but calpeptin has independent pro-apoptotic effectsAdam M Gwozdz, Roland Leung, Hong Wang, et al.
The Oncologist|August 14, 2014
Advanced pancreatic cancer: flourishing novel approaches in the era of biological therapyJoanne W Chiu, Hilda Wong, Roland Leung, et al.
Anti-Cancer Agents in Medicinal Chemistry|October 25, 2012
Advances in the systemic treatment of neuroendocrine tumors in the era of molecular therapyRoland Leung, Brian Lang, Hilda Wong, et al.
Cancers|May 4, 2026
Anti-Tumor Immunity in Solid-Organ Transplant RecipientsJeffrey Sum Lung Wong, Karen Hoi Lam Li, Bryan Li, et al.
Advances in Therapy|October 26, 2021
Neoadjuvant Therapy with Concurrent Docetaxel, Epirubicin, and Cyclophosphamide (TEC) in High-Risk HER2-Negative Breast CancersBryan Li, Thomas Yau, Roland Leung, et al.
Expert Review of Gastroenterology & Hepatology|March 5, 2021
Nivolumab + Ipilimumab for patients with hepatocellular carcinoma previously treated with SorafenibJosephine Tsang, Jeffrey Sum Lung Wong, Gerry Gin Wai Kwok, et al.
Pageof 4